Vivo Bio Tech has informed that, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from October 01, 2026 till the end of 48 hours after the declaration of the Unaudited Standalone and Consolidates Financial Results of the Company for the Second quarter ended September 30, 2026.
The above information is a part of company’s filings submitted to BSE.